GE HealthCare Technologies (GEHC)

The business is organized around four main areas: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. Imaging includes modalities such as magnetic resonance, computed tomography, X-ray, molecular imaging, and related service offerings. Ultrasound and visualization technologies support specialties including cardiology, women’s health, emergency medicine, and point-of-care diagnostics. Patient care products include monitoring, anesthesia, and maternal-infant care equipment. Pharmaceutical Diagnostics supplies contrast agents and other products used alongside imaging procedures.

A distinctive feature of GE HealthCare is the mix of capital equipment and recurring revenue. Hospitals purchase large systems that can remain in service for many years, while the company also earns revenue from maintenance, upgrades, consumables, digital tools, and pharmaceutical diagnostic products. This installed base gives the business ongoing customer relationships and exposure to replacement cycles, service contracts, and clinical workflow software.

GE HealthCare operates across major regions including the United States, Europe, the Middle East and Africa, China, and other international markets. Its performance is influenced by hospital capital spending, procedure volumes, healthcare infrastructure investment, regulation, reimbursement trends, and innovation in imaging and digital healthcare. The company competes in markets where reliability, clinical accuracy, service networks, and installed-base scale are critical advantages.